Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon

G. L. Nunes, C. N. Thomas, S. R. Hanson, J. J. Barry, S. B. King, N. A. Scott

Research output: Contribution to journalArticle

Abstract

Background: Systemic administration of heparin can decrease mortality and morbidity of acute ischemic coronary syndromes such as unstable angina and myocardial infarction. Hemorrhage is the major limiting factor in the clinical use of systemic heparin. The objective of the present study was to determine whether local delivery of heparin could inhibit platelet-dependent thrombosis without altering systemic bleeding parameters. Methods and Results: Hydrogel-coated angioplasty balloon catheters were dipped in a heparin solution, dried, and applied to a platelet-rich mural thrombus in a chronic ex vivo porcine arteriovenous shunt. 111In-labeled platelet deposition was quantified by gamma camera imaging. In a separate series of experiments, 3H-heparin was used to estimate the amount of heparin delivered to the thrombus with the coated balloon. Systemic heparin administration produced a dose-dependent decrease in platelet-dependent thrombus formation that was maximal at 200 units/kg. Bleeding times and activated partial thromboplastin times were prolonged at this dose. An equal inhibition of thrombus formation was achieved after the coated balloon was dipped in a heparin solution (10 000 units/mL) and deployed at the mural thrombus. In contrast to systemic heparin administration, there was no alteration in bleeding parameters associated with local heparin delivery. The estimated amount of heparin delivered with the coated balloon was 40 units. Conclusions: Local delivery of heparin in amounts sufficient to inhibit platelet-dependent thrombosis can be accomplished with a hydrogel-coated coronary angioplasty balloon catheter. Local heparin delivery can inhibit thrombus formation in amounts that are several orders of magnitude lower than the required systemic dose. Local delivery of heparin was not associated with prolongation of bleeding parameters.

Original languageEnglish (US)
Pages (from-to)1697-1700
Number of pages4
JournalCirculation
Volume92
Issue number7
StatePublished - 1995
Externally publishedYes

Fingerprint

Hydrogel
Heparin
Thrombosis
Blood Platelets
Hemorrhage
Catheters
Bleeding Time
Coronary Balloon Angioplasty
Balloon Angioplasty
Partial Thromboplastin Time
Unstable Angina
Acute Coronary Syndrome
Radionuclide Imaging

Keywords

  • heparin
  • thrombosis

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Nunes, G. L., Thomas, C. N., Hanson, S. R., Barry, J. J., King, S. B., & Scott, N. A. (1995). Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon. Circulation, 92(7), 1697-1700.

Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon. / Nunes, G. L.; Thomas, C. N.; Hanson, S. R.; Barry, J. J.; King, S. B.; Scott, N. A.

In: Circulation, Vol. 92, No. 7, 1995, p. 1697-1700.

Research output: Contribution to journalArticle

Nunes, GL, Thomas, CN, Hanson, SR, Barry, JJ, King, SB & Scott, NA 1995, 'Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon', Circulation, vol. 92, no. 7, pp. 1697-1700.
Nunes GL, Thomas CN, Hanson SR, Barry JJ, King SB, Scott NA. Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon. Circulation. 1995;92(7):1697-1700.
Nunes, G. L. ; Thomas, C. N. ; Hanson, S. R. ; Barry, J. J. ; King, S. B. ; Scott, N. A. / Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon. In: Circulation. 1995 ; Vol. 92, No. 7. pp. 1697-1700.
@article{7656eca8bf7f4b2aa6baa0cd460028b7,
title = "Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon",
abstract = "Background: Systemic administration of heparin can decrease mortality and morbidity of acute ischemic coronary syndromes such as unstable angina and myocardial infarction. Hemorrhage is the major limiting factor in the clinical use of systemic heparin. The objective of the present study was to determine whether local delivery of heparin could inhibit platelet-dependent thrombosis without altering systemic bleeding parameters. Methods and Results: Hydrogel-coated angioplasty balloon catheters were dipped in a heparin solution, dried, and applied to a platelet-rich mural thrombus in a chronic ex vivo porcine arteriovenous shunt. 111In-labeled platelet deposition was quantified by gamma camera imaging. In a separate series of experiments, 3H-heparin was used to estimate the amount of heparin delivered to the thrombus with the coated balloon. Systemic heparin administration produced a dose-dependent decrease in platelet-dependent thrombus formation that was maximal at 200 units/kg. Bleeding times and activated partial thromboplastin times were prolonged at this dose. An equal inhibition of thrombus formation was achieved after the coated balloon was dipped in a heparin solution (10 000 units/mL) and deployed at the mural thrombus. In contrast to systemic heparin administration, there was no alteration in bleeding parameters associated with local heparin delivery. The estimated amount of heparin delivered with the coated balloon was 40 units. Conclusions: Local delivery of heparin in amounts sufficient to inhibit platelet-dependent thrombosis can be accomplished with a hydrogel-coated coronary angioplasty balloon catheter. Local heparin delivery can inhibit thrombus formation in amounts that are several orders of magnitude lower than the required systemic dose. Local delivery of heparin was not associated with prolongation of bleeding parameters.",
keywords = "heparin, thrombosis",
author = "Nunes, {G. L.} and Thomas, {C. N.} and Hanson, {S. R.} and Barry, {J. J.} and King, {S. B.} and Scott, {N. A.}",
year = "1995",
language = "English (US)",
volume = "92",
pages = "1697--1700",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon

AU - Nunes, G. L.

AU - Thomas, C. N.

AU - Hanson, S. R.

AU - Barry, J. J.

AU - King, S. B.

AU - Scott, N. A.

PY - 1995

Y1 - 1995

N2 - Background: Systemic administration of heparin can decrease mortality and morbidity of acute ischemic coronary syndromes such as unstable angina and myocardial infarction. Hemorrhage is the major limiting factor in the clinical use of systemic heparin. The objective of the present study was to determine whether local delivery of heparin could inhibit platelet-dependent thrombosis without altering systemic bleeding parameters. Methods and Results: Hydrogel-coated angioplasty balloon catheters were dipped in a heparin solution, dried, and applied to a platelet-rich mural thrombus in a chronic ex vivo porcine arteriovenous shunt. 111In-labeled platelet deposition was quantified by gamma camera imaging. In a separate series of experiments, 3H-heparin was used to estimate the amount of heparin delivered to the thrombus with the coated balloon. Systemic heparin administration produced a dose-dependent decrease in platelet-dependent thrombus formation that was maximal at 200 units/kg. Bleeding times and activated partial thromboplastin times were prolonged at this dose. An equal inhibition of thrombus formation was achieved after the coated balloon was dipped in a heparin solution (10 000 units/mL) and deployed at the mural thrombus. In contrast to systemic heparin administration, there was no alteration in bleeding parameters associated with local heparin delivery. The estimated amount of heparin delivered with the coated balloon was 40 units. Conclusions: Local delivery of heparin in amounts sufficient to inhibit platelet-dependent thrombosis can be accomplished with a hydrogel-coated coronary angioplasty balloon catheter. Local heparin delivery can inhibit thrombus formation in amounts that are several orders of magnitude lower than the required systemic dose. Local delivery of heparin was not associated with prolongation of bleeding parameters.

AB - Background: Systemic administration of heparin can decrease mortality and morbidity of acute ischemic coronary syndromes such as unstable angina and myocardial infarction. Hemorrhage is the major limiting factor in the clinical use of systemic heparin. The objective of the present study was to determine whether local delivery of heparin could inhibit platelet-dependent thrombosis without altering systemic bleeding parameters. Methods and Results: Hydrogel-coated angioplasty balloon catheters were dipped in a heparin solution, dried, and applied to a platelet-rich mural thrombus in a chronic ex vivo porcine arteriovenous shunt. 111In-labeled platelet deposition was quantified by gamma camera imaging. In a separate series of experiments, 3H-heparin was used to estimate the amount of heparin delivered to the thrombus with the coated balloon. Systemic heparin administration produced a dose-dependent decrease in platelet-dependent thrombus formation that was maximal at 200 units/kg. Bleeding times and activated partial thromboplastin times were prolonged at this dose. An equal inhibition of thrombus formation was achieved after the coated balloon was dipped in a heparin solution (10 000 units/mL) and deployed at the mural thrombus. In contrast to systemic heparin administration, there was no alteration in bleeding parameters associated with local heparin delivery. The estimated amount of heparin delivered with the coated balloon was 40 units. Conclusions: Local delivery of heparin in amounts sufficient to inhibit platelet-dependent thrombosis can be accomplished with a hydrogel-coated coronary angioplasty balloon catheter. Local heparin delivery can inhibit thrombus formation in amounts that are several orders of magnitude lower than the required systemic dose. Local delivery of heparin was not associated with prolongation of bleeding parameters.

KW - heparin

KW - thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0029128398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029128398&partnerID=8YFLogxK

M3 - Article

C2 - 7671350

AN - SCOPUS:0029128398

VL - 92

SP - 1697

EP - 1700

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 7

ER -